Passage BIO annual free cash flow
2019
2020
2021
2022
2023
2024
Passage BIO Free Cash Flow (FCF) History (PASG)
Passage BIO reported −$48.0M in free cash flow for fiscal 2024, an increase of $30.4M from the previous fiscal year.
View full Passage BIO company overviewPassage BIO free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$48.0M | $30.4M | — | — |
| 2023 | 2023-12-31 | −$78.4M | $42.1M | — | — |
| 2022 | 2022-12-31 | −$120.5M | $24.0M | — | — |
| 2021 | 2021-12-31 | −$144.5M | −$62.9M | — | — |
| 2020 | 2020-12-31 | −$81.7M | −$40.6M | — | — |
| 2019 | 2019-12-31 | −$41.1M | — | — | — |
Passage BIO quarterly free cash flow
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | −$19.5M | $5.0M | — | — |
| Q3 2023 | 2023-09-30 | −$19.2M | $4.5M | — | — |
| Q2 2023 | 2023-06-30 | −$17.2M | $9.7M | — | — |
| Q1 2023 | 2023-03-31 | −$22.5M | $23.0M | — | — |
| Q4 2022 | 2022-12-31 | −$24.5M | $13.1M | — | — |
| Q3 2022 | 2022-09-30 | −$23.6M | $23.4M | — | — |
| Q2 2022 | 2022-06-30 | −$26.9M | $1.4M | — | — |
| Q1 2022 | 2022-03-31 | −$45.4M | −$13.9M | — | — |
| Q4 2021 | 2021-12-31 | −$37.6M | −$7.4M | — | — |
| Q3 2021 | 2021-09-30 | −$47.1M | −$29.4M | — | — |
| Q2 2021 | 2021-06-30 | −$28.3M | −$16.5M | — | — |
| Q1 2021 | 2021-03-31 | −$31.5M | −$9.6M | — | — |
| Q4 2020 | 2020-12-31 | −$30.2M | −$12.7M | — | — |
| Q3 2020 | 2020-09-30 | −$17.7M | −$6.1M | — | — |
| Q2 2020 | 2020-06-30 | −$11.8M | −$872,000 | — | — |
| Q1 2020 | 2020-03-31 | −$21.9M | −$20.9M | — | — |
| Q4 2019 | 2019-12-31 | −$17.5M | — | — | — |
| Q3 2019 | 2019-09-30 | −$11.5M | — | — | — |
| Q2 2019 | 2019-06-30 | −$10.9M | — | — | — |
| Q1 2019 | 2019-03-31 | −$1.1M | — | — | — |
Passage BIO free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$41.1M to −$48.0M, a net decrease of $6.9M. Passage BIO's latest reported quarter, Q4 2023, generated −$19.5M in free cash flow, an increase of $5.0M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Passage BIO filings at SEC.gov ↗